Beijing Aerospace Changfeng Co Ltd
SSE:600855
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.97
14.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Beijing Aerospace Changfeng Co Ltd
Cash & Cash Equivalents
Beijing Aerospace Changfeng Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Aerospace Changfeng Co Ltd
SSE:600855
|
Cash & Cash Equivalents
¥809m
|
CAGR 3-Years
2%
|
CAGR 5-Years
27%
|
CAGR 10-Years
7%
|
|
|
CITIC Ltd
HKEX:267
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fosun International Ltd
HKEX:656
|
Cash & Cash Equivalents
¥109.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
|
J
|
Jiangsu Yueda Investment Co Ltd
SSE:600805
|
Cash & Cash Equivalents
¥895.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
|
Zhe Jiang Jian Feng Group Co Ltd
SSE:600668
|
Cash & Cash Equivalents
¥205.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
6%
|
|
|
C
|
China Baoan Group Co Ltd
SZSE:000009
|
Cash & Cash Equivalents
¥7.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
Beijing Aerospace Changfeng Co Ltd
Glance View
Beijing Aerospace Changfeng Co., Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Beijing, Beijing and currently employs 1,706 full-time employees. The firm operates its business through four segments. The Security Technology segment mainly provides the security solutions of technical advice, product development, system integration, project implementation. The Medical Devices segment is mainly engaged in the research and development, production and sales of ventilator, anesthesia machine, surgical lamp, operating bed, handheld ultrasonic diagnostic equipment and neural brain electrical equipment. The Electronic Information segment is mainly engaged in the research and development, production and sales of special computers and infrared optoelectronic products. The Computer Numerical Control (CNC) Machine Tool segment is mainly engaged in the research and development, production and sales of CNC machine tool system. The firm operates its business in the domestic market and overseas markets.
See Also
What is Beijing Aerospace Changfeng Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
809m
CNY
Based on the financial report for Jun 30, 2024, Beijing Aerospace Changfeng Co Ltd's Cash & Cash Equivalents amounts to 809m CNY.
What is Beijing Aerospace Changfeng Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
7%
Over the last year, the Cash & Cash Equivalents growth was -10%. The average annual Cash & Cash Equivalents growth rates for Beijing Aerospace Changfeng Co Ltd have been 2% over the past three years , 27% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
